Brief: Delcath Systems Announces Update To National Comprehensive Cancer Network Clinical Practice Guidelines
14/02/2025 13:39
Feb 14 (Reuters) - Delcath Systems DCTH.O :
* DELCATH SYSTEMS ANNOUNCES UPDATE TO NATIONAL COMPREHENSIVE
CANCER NETWORK CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT OF
METASTATIC UVEAL MELANOMA
* DELCATH SYSTEMS: UPDATED NCCN GUIDELINES INCLUDE HEPZATO
KIT AS
CATEGORY 2A TREATMENT FOR PATIENTS WITH HEPATIC-DOMINANT UVEAL
MELANOMA
Source text: ID:nBw4Rt5FZa
Further company coverage: DCTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Delcath Systems
See all newsBrief: Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Delcath Systems Q1 revenue beats on Hepzato growth
Brief: Delcath Systems Announces Publication Of Chopin Clinical Trial Results In The Lancet Oncology
Delcath Q4 revenue rises 37%, beats estimates
Brief: Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)